M. Moulard

发表

Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120

J. Sodroski, Q. Sattentau, R. Wyatt, 2000, Journal of Virology.

HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4.

Q. Sattentau, J. Hoxie, J. Davoust, 1997, Journal of immunology.

Role of receptor occupancy assays by flow cytometry in drug development

J. Ferbas, V. Litwin, K. Czechowska, 2016, Cytometry. Part B, Clinical cytometry.

How validated receptor occupancy flow cytometry assays can impact decisions and support drug development

M. Moulard, M. Ozoux, 2016, Cytometry. Part B, Clinical cytometry.

Effects of calcium ions on proteolytic processing of HIV‐1 gp160 precursor and on cell fusion

L. Montagnier, E. Bahraoui, M. Moulard, 1994, FEBS letters.

Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y12 inhibition

P. Barragan, Shinji Yamaguchi, J. Jakubowski, 2011, Thrombosis and Haemostasis.

Ion channel activation by SPC3, a peptide derived from the HIV-1 gp120 V3 loop.

E. Carlier, H. Rochat, K. Mabrouk, 2000, The journal of peptide research : official journal of the American Peptide Society.

Selective HIV-1-induced downmodulation of CD4 and coreceptors

Q. Sattentau, M. Moulard, A. Chenine, 2000, Archives of Virology.

Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors.

J. Timmer, U. Walter, R. Mark, 2014, European journal of pharmacology.

Further studies on the human pancreatic binary complexes involving procarboxypeptidase A

T. Michon, B. Kerfelec, C. Chapus, 1990, FEBS letters.

V3 loop-derived peptide SPC3 inhibits infection of CD4- and galactosylceramide- cells by LAV-2/B.

H. Rochat, K. Mabrouk, J. Sabatier, 1999, Journal of Peptide Research.

T4-lymphocyte endoprotease responsible for the proteolytic processing of HIV-1 gp160, like Kex2p endoprotease, is a calcium-dependent enzyme.

E. Bahraoui, T. Achstetter, M. Moulard, 1994, Biochimie.

Processing and routage of HIV glycoproteins by furin to the cell surface.

H. Klenk, W. Garten, S. Hallenberger, 1999, Virus research.

Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.

J. Sodroski, Q. Sattentau, J. Hoxie, 1998, Virology.

Recommendations for the development and validation of flow cytometry‐based receptor occupancy assays

John Ferbas, Virginia Litwin, Carl-Magnus Högerkorp, 2016, Cytometry. Part B, Clinical cytometry.

A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: proof of principle with rituximab and ofatumumab.

P. Parren, F. Beurskens, P. Engelberts, 2013, Journal of immunological methods.

Maturation of HIV envelope glycoprotein precursors by cellular endoproteases.

E. Decroly, M. Moulard, Maxime Moulard, 2000, Biochimica et biophysica acta.

Selective Interactions of Polyanions with Basic Surfaces on Human Immunodeficiency Virus Type 1 gp120

J. Sodroski, Q. Sattentau, R. Wyatt, 2000, Journal of Virology.

Heterogeneity of Envelope Molecules Expressed on Primary Human Immunodeficiency Virus Type 1 Particles as Probed by the Binding of Neutralizing and Nonneutralizing Antibodies

D. Burton, P. Parren, P. Poignard, 2003, Journal of Virology.

Antibody neutralization of HIV-1 and the potential for vaccine design.

Q. Sattentau, P. Poignard, J. Guillemot, 1999, Immunology letters.

Interferon-Independent, Human Immunodeficiency Virus Type 1 gp120-Mediated Induction of CXCL10/IP-10 Gene Expression by Astrocytes In Vivo and In Vitro

H. Fox, I. Campbell, R. Milner, 2001, Journal of Virology.

UvA-DARE ( Digital Academic Repository ) Neutralizing antibodies to the HIV-1 envelope glycoproteins

C. Broder, J. Binley, D. Burton, 2009 .

The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells

H. Klenk, M. Sordel, W. Garten, 1997, Journal of virology.

Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.

M. Kieny, L. Montagnier, E. Bahraoui, 1994, European journal of biochemistry.

Validation of a novel ELISA-based VASP whole blood assay to measure P2Y12-ADP receptor activity

P. Barragan, L. Bonello, F. Paganelli, 2010, Thrombosis and Haemostasis.

Identification of a procarboxypeptidase A‐truncated protease E binary complex in human pancreatic juice

B. Mallet, B. Kerfelec, C. Chapus, 1989, FEBS letters.

Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytes.

H. Rochat, K. Mabrouk, M. De Waard, 2002, Antiviral research.

Evaluation of structure-antigenicity relationship of peptides from human immunodeficiency virus type 1 (HIV-1) p18 protein by circular dichroism.

H. Rochat, E. Bahraoui, K. Mabrouk, 1993, Molecular immunology.

Abstract 2908: A first-in-human phase I study of SAR650984, a humanized anti-CD38 antibody in patients with CD38+ hematological malignancies: Preliminary PK and PD results of escalation phase

C. Veyrat‐Follet, H. Guillemin, D. Valente, 2014 .

Comparison of Cell Lysis Mediated by LFB-R603 with That Mediated by Ofatumumab Against Cells Expressing Low Levels of CD20,

J. Prost, M. Salcedo, A. Bellon, 2011 .

Retroviral envelope glycoprotein processing: structural investigation of the cleavage site.

L. Chaloin, K. Mabrouk, H. Darbon, 1998, Biochemistry.

Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV‐1)

K. Mabrouk, J. Sabatier, J. Gluckman, 1993, FEBS letters.

Novel Hiv Neutralizing Antibodies Selected from Phage Display Libraries

D. Dimitrov, Mei-Yun Zhang, M. Moulard, 2004 .

Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope.

E. Fenouillet, H. Rochat, K. Mabrouk, 1996, Virology.

A multiple branch peptide construction derived from a conserved sequence of the envelope glycoprotein gp41 inhibits human immunodeficiency virus infection

E. Fenouillet, H. Rochat, K. Mabrouk, 2002 .